2015
DOI: 10.1021/acs.accounts.5b00270
|View full text |Cite
|
Sign up to set email alerts
|

Red-Shifting Azobenzene Photoswitches for in Vivo Use

Abstract: Recently, there has been a great deal of interest in using the photoisomerization of azobenzene compounds to control specific biological targets in vivo. These azo compounds can be used as research tools or, in principle, could act as optically controlled drugs. Such "photopharmaceuticals" offer the prospect of targeted drug action and an unprecedented degree of temporal control. A key feature of azo compounds designed to photoswitch in vivo is the wavelength of light required to cause the photoisomerization. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

9
450
0
8

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 529 publications
(485 citation statements)
references
References 69 publications
9
450
0
8
Order By: Relevance
“…[7][8][9][10][11][12] Applications differ markedly in the environment the photoswitch is exposed to,b ei td ifferent solvents, [13,14] matrices or surfaces,a nd understanding how ag iven photoswitch behaves in various environments is crucial for its success in any applications. Donor-acceptor Stenhouse adducts (DASAs,F igure 1a) were introduced in 2014 [17,18] and feature important advantages as compared to traditional photoswitches,i ncluding visible light responsiveness [11,19,20] and negative photochromism. [21] Moreover,t heir modular architecture [22] allows for afine-tuning of properties.…”
mentioning
confidence: 99%
“…[7][8][9][10][11][12] Applications differ markedly in the environment the photoswitch is exposed to,b ei td ifferent solvents, [13,14] matrices or surfaces,a nd understanding how ag iven photoswitch behaves in various environments is crucial for its success in any applications. Donor-acceptor Stenhouse adducts (DASAs,F igure 1a) were introduced in 2014 [17,18] and feature important advantages as compared to traditional photoswitches,i ncluding visible light responsiveness [11,19,20] and negative photochromism. [21] Moreover,t heir modular architecture [22] allows for afine-tuning of properties.…”
mentioning
confidence: 99%
“…Reversible activation of ligands is achieved through the use of proteins containing photolabile domains, also known as photoswitches. The most common photoswtich used is azobenzene, originally sensitive to UV light; red shifted versions have developed to allow for use in vivo [67,68*] (Figure 2c). A photoswitchable small molecule mu opioid agonist fentanyl has also been developed as well using this approach [69].…”
Section: Photopharmacologymentioning
confidence: 99%
“…Moreover, it can be easily tuned in terms of wavelength and intensity and it can be applied with high spatiotemporal control. These advantages have stimulated the application of light‐driven molecular switches14 and motors in functional materials8, 15, 16, 17, 18, 19, 20 and biological systems 21, 22, 23, 24. However, potentially harmful UV light is typically used for their operation while, for practical applications, the use of visible light is often desired 25, 26, 27, 28, 29, 30, 31…”
mentioning
confidence: 99%